Seeking Alpha

Peregrine Pharma EPS in-line, beats on revenue

  • Peregrine Pharma (PPHM): FQ2 EPS of -$0.05 in-line.
  • Revenue of $7.35M beats by $1.61M. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector